The PATH model's validity, and its focus on measuring personal health priorities--is demonstrated by its proven ability to predict the use of prescription drugs among adults independently of disease states.

Pharmacy claims data recently collected from over 13,000 health plan members broken out by PATH Type reveals dramatic differences in demand. The variances in the above slides are tied to the differences in the healthcare attitudes, behaviors and priorities of the individuals in each group. To the extent that the value of any consumer segmentation is its ability to predict pharmaceutical revenues, the archetypes identified by the PATH model reveal a spread of about $6,000 per person per year in pharmacy claims paid by health plans.